Zobrazeno 1 - 10
of 1 362
pro vyhledávání: '"Pisati F."'
Autor:
Varinelli L; Molecular Epigenomics Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy., Di Bella M; Molecular Epigenomics Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy., Guaglio M; Peritoneal Surface Malignancies Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy., Battistessa D; Molecular Epigenomics Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy., Pisati F; Cogentech Ltd. Benefit Corporation with a Sole Shareholder, Milan, Italy., Cavalleri T; Peritoneal Surface Malignancies Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy., Milione M; 1st Pathology Division, Department of Phatology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Martínez-Quintanilla J; Translational Program, Stem Cells and Cancer Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Caswell PT; Wellcome Trust Centre for Cell-Matrix Research, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK., Baratti D; Peritoneal Surface Malignancies Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy., Kusamura S; Peritoneal Surface Malignancies Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy., Deraco M; Peritoneal Surface Malignancies Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy., Gariboldi M; Molecular Epigenomics Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy.
Publikováno v:
Journal of surgical oncology [J Surg Oncol] 2024 Oct 03. Date of Electronic Publication: 2024 Oct 03.
Autor:
Varinelli L; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Battistessa D; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Guaglio M; Peritoneal Surface Malignancies Unit, Colorectal Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Zanutto S; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Illescas O; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Lorenc EJ; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Pisati F; Cogentech Ltd. Benefit Corporation With a Sole Shareholder, Via Adamello 16, Milan, 20139, Italy., Kusamura S; Peritoneal Surface Malignancies Unit, Colorectal Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Cattaneo L; Pathology and Laboratory Medicine Department, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Via G. Venezian 1, Milan, 20133, Italy., Sabella G; Pathology and Laboratory Medicine Department, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Via G. Venezian 1, Milan, 20133, Italy., Milione M; Pathology and Laboratory Medicine Department, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Via G. Venezian 1, Milan, 20133, Italy., Perbellini A; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Noci S; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Paolino C; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Kuhn E; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, 20122, Italy.; Pathology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, 20122, Italy., Galassi M; Centrale Produzione Farmaci, Hospital Pharmacy, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Via G. Venezian 1, Milan, 20133, Italy., Cavalleri T; Peritoneal Surface Malignancies Unit, Colorectal Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Deraco M; Peritoneal Surface Malignancies Unit, Colorectal Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy. marcello.deraco@istitutotumori.mi.it., Gariboldi M; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Baratti D; Peritoneal Surface Malignancies Unit, Colorectal Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Jun 11; Vol. 43 (1), pp. 162. Date of Electronic Publication: 2024 Jun 11.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Frittoli E., Palamidessi A., Iannelli F., Zanardi F., Villa S., Barzaghi L., Abdo H., Cancila V., Beznoussenko G. V., Della Chiara G., Pagani M., Malinverno C., Bhattacharya D., Pisati F., Yu W., Galimberti V., Bonizzi G., Martini E., Mironov A. A., Gioia U., Ascione F., Li Q., Havas K., Magni S., Lavagnino Z., Pennacchio F. A., Maiuri P., Caponi S., Mattarelli M., Martino S., d'Adda di Fagagna F., Rossi C., Lucioni M., Tancredi R., Pedrazzoli P., Vecchione A., Petrini C., Ferrari F., Lanzuolo C., Bertalot G., Nader G., Foiani M., Piel M., Cerbino R., Giavazzi F., Tripodo C., Scita G.
Publikováno v:
Nature Materials
The process in which locally confined epithelial malignancies progressively evolve into invasive cancers is often promoted by unjamming, a phase transition from a solid-like to a liquid-like state, which occurs in various tissues. Whether this tissue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0059044f8ce737cff08eef4e574e4d4f
https://hdl.handle.net/21.11116/0000-000C-A828-A21.11116/0000-000C-A82A-8
https://hdl.handle.net/21.11116/0000-000C-A828-A21.11116/0000-000C-A82A-8
Autor:
Varinelli L; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Battistessa D; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Guaglio M; Peritoneal Surface Malignancies Unit, Colorectal Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Zanutto S; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Illescas O; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Lorenc EJ; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Pisati F; Cogentech Ltd. Benefit Corporation With a Sole Shareholder, Via Adamello 16, Milan, 20139, Italy., Kusamura S; Peritoneal Surface Malignancies Unit, Colorectal Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Cattaneo L; Pathology and Laboratory Medicine Department, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Via G. Venezian 1, Milan, 20133, Italy., Sabella G; Pathology and Laboratory Medicine Department, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Via G. Venezian 1, Milan, 20133, Italy., Milione M; Pathology and Laboratory Medicine Department, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Via G. Venezian 1, Milan, 20133, Italy., Perbellini A; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Noci S; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Paolino C; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Kuhn E; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, 20122, Italy.; Pathology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, 20122, Italy., Galassi M; Centrale Produzione Farmaci, Hospital Pharmacy, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Via G. Venezian 1, Milan, 20133, Italy., Cavalleri T; Peritoneal Surface Malignancies Unit, Colorectal Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Deraco M; Peritoneal Surface Malignancies Unit, Colorectal Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy. marcello.deraco@istitutotumori.mi.it., Gariboldi M; Department of Experimental Oncology, Molecular Epigenomics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy., Baratti D; Peritoneal Surface Malignancies Unit, Colorectal Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, Milan, 20133, Italy.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 May 02; Vol. 43 (1), pp. 132. Date of Electronic Publication: 2024 May 02.
Autor:
Frittoli E., Palamidessi A., Iannelli F., Zanardi F., Villa S., Barzaghi L., Abdo H., Cancila V., Beznoussenko G. V., Della Chiara G., Pagani M., Malinverno C., Bhattacharya D., Pisati F., Yu W., Galimberti V., Bonizzi G., Martini E., Mironov A. A., Gioia U., Ascione F., Li Q., Havas K., Magni S., Lavagnino Z., Pennacchio F. A., Maiuri P., Caponi S., Mattarelli M., Martino S., d'Adda di Fagagna F., Rossi C., Lucioni M., Tancredi R., Pedrazzoli P., Vecchione A., Petrini C., Ferrari F., Lanzuolo C., Bertalot G., Nader G., Foiani M., Piel M., Cerbino R., Giavazzi F., Tripodo C., Scita G.
In the version of this article initially published, the first name of Flora Ascione was listed as “Floriana”; the error has been corrected in the HTML and PDF versions of the article.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::cdff068e80e2f5322ec173d7cc5d559c
https://hdl.handle.net/10447/584375
https://hdl.handle.net/10447/584375
Autor:
Farris F; IFOM ETS - The AIRC Institute of Molecular Oncology, 20139, Milan, Italy., Elhagh A; IFOM ETS - The AIRC Institute of Molecular Oncology, 20139, Milan, Italy., Vigorito I; IFOM ETS - The AIRC Institute of Molecular Oncology, 20139, Milan, Italy., Alongi N; IFOM ETS - The AIRC Institute of Molecular Oncology, 20139, Milan, Italy.; IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Pisati F; Histopathology Unit, Cogentech S.C.a.R.L, 20139, Milan, Italy., Giannattasio M; IFOM ETS - The AIRC Institute of Molecular Oncology, 20139, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20122, Milan, Italy., Casagrande F; IFOM ETS - The AIRC Institute of Molecular Oncology, 20139, Milan, Italy.; Human Technopole, Milan, Italy., Veghini L; Department of Engineering for Innovation Medicine (DIMI), University of Verona, 37134, Verona, Italy., Corbo V; Department of Engineering for Innovation Medicine (DIMI), University of Verona, 37134, Verona, Italy.; ARC-Net Centre for Applied Research on Cancer, University of Verona, 37134, Verona, Italy., Tripodo C; IFOM ETS - The AIRC Institute of Molecular Oncology, 20139, Milan, Italy.; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, 90133, Palermo, Italy., Di Napoli A; Pathology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, 00189, Rome, Italy., Matafora V; IFOM ETS - The AIRC Institute of Molecular Oncology, 20139, Milan, Italy. vittoria.matafora@ifom.eu., Bachi A; IFOM ETS - The AIRC Institute of Molecular Oncology, 20139, Milan, Italy. angela.bachi@ifom.eu.
Publikováno v:
Cell death & disease [Cell Death Dis] 2024 Jan 11; Vol. 15 (1), pp. 28. Date of Electronic Publication: 2024 Jan 11.
Autor:
Villani A; Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Fontana A; Biostatistic Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Panebianco C; Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Ferro C; Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Copetti M; Biostatistic Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Pavlovic R; Proteomics and Metabolomics Facility (ProMeFa), IRCCS San Raffaele Scientific Institute, Milan, Italy., Drago D; Proteomics and Metabolomics Facility (ProMeFa), IRCCS San Raffaele Scientific Institute, Milan, Italy., Fiorentini C; Scientific Direction, Association for Research on Integrative Oncological Therapies (ARTOI), Roma, Italy., Terracciano F; Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Bazzocchi F; Abdominal Surgery Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Canistro G; Abdominal Surgery Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Pisati F; Histopathology Unit, Cogentech S.C.a.R.L, Milan, Italy., Maiello E; Oncology Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Latiano TP; Oncology Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Perri F; Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Pazienza V; Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Publikováno v:
Gut microbes [Gut Microbes] 2024 Jan-Dec; Vol. 16 (1), pp. 2375483. Date of Electronic Publication: 2024 Jul 07.
Autor:
Aprile S, Colombo G, Serafini M, Di Paola R, Pisati F, Bhela IP, Cuzzocrea S, Grosa G, Pirali T
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2023 Nov 27; Vol. 14 (12), pp. 1891-1892. Date of Electronic Publication: 2023 Nov 27 (Print Publication: 2023).
Autor:
Hershey BJ; IFOM ETS The AIRC Institute of Molecular Oncology, Milan, Italy., Barozzi S; IFOM ETS The AIRC Institute of Molecular Oncology, Milan, Italy., Orsenigo F; IFOM ETS The AIRC Institute of Molecular Oncology, Milan, Italy., Pompei S; IFOM ETS The AIRC Institute of Molecular Oncology, Milan, Italy., Iannelli F; IFOM ETS The AIRC Institute of Molecular Oncology, Milan, Italy., Kamrad S; Medical Research Council Toxicology Unit, Cambridge, UK., Matafora V; IFOM ETS The AIRC Institute of Molecular Oncology, Milan, Italy., Pisati F; Histopathology Unit, Cogentech S.C.A.R.L., Milan, Italy., Calabrese L; IFOM ETS The AIRC Institute of Molecular Oncology, Milan, Italy., Fragale G; IFOM ETS The AIRC Institute of Molecular Oncology, Milan, Italy., Salvadori G; IFOM ETS The AIRC Institute of Molecular Oncology, Milan, Italy., Martini E; IFOM ETS The AIRC Institute of Molecular Oncology, Milan, Italy., Totaro MG; IFOM ETS The AIRC Institute of Molecular Oncology, Milan, Italy., Magni S; IFOM ETS The AIRC Institute of Molecular Oncology, Milan, Italy., Guan R; Medical Research Council Toxicology Unit, Cambridge, UK., Parazzoli D; IFOM ETS The AIRC Institute of Molecular Oncology, Milan, Italy., Maiuri P; University of Naples Federico II, Naples, Italy., Bachi A; IFOM ETS The AIRC Institute of Molecular Oncology, Milan, Italy., Patil KR; Medical Research Council Toxicology Unit, Cambridge, UK., Cosentino Lagomarsino M; IFOM ETS The AIRC Institute of Molecular Oncology, Milan, Italy.; University of Milano, Milan, Italy., Havas KM; IFOM ETS The AIRC Institute of Molecular Oncology, Milan, Italy.
Publikováno v:
Science advances [Sci Adv] 2023 Sep 15; Vol. 9 (37), pp. eadh4184. Date of Electronic Publication: 2023 Sep 15.